Using the activity tracking separation method, the compound bufalin, which has the activity of inhibiting the growth of tumor cells and low acute toxicity to mice, was isolated from bufalin. It has a good growth inhibition effect on human non-small cell lung cancer A549 cells. The LD50 of IV administration in mice is about 4 times that of bufalin, and the stability is good.